Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Substitutes 1

Interventions

Specimen Handling 3 Cisplatin 3 Magnetic Resonance Spectroscopy 2 Letrozole 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Diosmin 2 Carboplatin 2 trametinib 1 toripalimab 1 tocilizumab 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 rozanolixizumab 1 pyrotinib 1 pirtobrutinib 1 olutasidenib 1 obinutuzumab 1 niraparib 1 naldemedine 1 idelalisib 1 human papillomavirus vaccine, L1 type 16, 18 1 fluciclovine F-18 1 enfortumab vedotin 1 darolutamide 1 dabrafenib 1 cabozantinib 1 apalutamide 1 adacel 1 acalabrutinib 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Skin, Artificial × 30 days × Clear all

NCT07587749 2026-05-14

Skin Subs vs Secondary Intention

Baylor Research Institute

Phase 4 Not yet recruiting

Skin Substitutes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡